IRLAB Therapeutics AB (publ) (IRLAB-A) — Tangible Net Worth Ratio
IRLAB Therapeutics AB (publ) (IRLAB-A) has a Tangible Net Worth Ratio of -52.6% as of December 2025. This metric is calculated by deducting intangible assets (Skr46.86 Million) from net assets (Skr30.72 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See IRLAB Therapeutics AB (publ) short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
IRLAB Therapeutics AB (publ) Tangible Net Worth Ratio (2013–2025)
This chart shows how IRLAB Therapeutics AB (publ)'s Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at -52.6%, reflecting net assets of Skr30.72 Million with intangible assets of Skr46.86 Million SEK. See IRLAB Therapeutics AB (publ) defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for IRLAB Therapeutics AB (publ) (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for IRLAB Therapeutics AB (publ) from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see IRLAB-A stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -52.6% | Skr30.72 Million | Skr46.86 Million | Skr138.21 Million | ▼ -9.0 pp |
| 2024 | -43.6% | Skr32.63 Million | Skr46.86 Million | Skr136.21 Million | ▼ -103.1 pp |
| 2023 | 59.5% | Skr115.76 Million | Skr46.86 Million | Skr177.12 Million | ▼ -24.4 pp |
| 2022 | 83.9% | Skr290.83 Million | Skr46.86 Million | Skr323.56 Million | ▼ -5.4 pp |
| 2021 | 89.3% | Skr399.48 Million | Skr42.66 Million | Skr472.45 Million | ▲ +12.9 pp |
| 2020 | 76.4% | Skr347.88 Million | Skr82.01 Million | Skr370.07 Million | ▲ +21.7 pp |
| 2019 | 54.8% | Skr181.83 Million | Skr82.27 Million | Skr208.07 Million | ▼ -6.1 pp |
| 2018 | 60.8% | Skr212.48 Million | Skr83.27 Million | Skr224.94 Million | ▲ +15.2 pp |
| 2017 | 45.6% | Skr155.00 Million | Skr84.27 Million | Skr162.97 Million | ▲ +26.7 pp |
| 2016 | 18.9% | Skr103.89 Million | Skr84.27 Million | Skr113.11 Million | ▲ +10.5 pp |
| 2015 | 8.4% | Skr92.03 Million | Skr84.27 Million | Skr101.09 Million | ▲ +3.6 pp |
| 2014 | 4.9% | Skr88.57 Million | Skr84.27 Million | Skr106.43 Million | ▼ -95.1 pp |
| 2013 | 100.0% | Skr24.99 Million | Skr0.00 | Skr25.00 Million | — |